ARCHIVES

FDA Blocks Nine More INDs; Cooperative Group Chairmen, DeVita Blast “Lack of Expertise”

This article is from The Cancer Letter archive.

Vol. 03 No. 01 | January 7, 1977

Download PDF Visit The Full Archive

Related Articles

Bonner to Succeed Stovall as NCCS President and CEO.

May 30, 2008

Abraxane-Gemcitabine Combination Extends Overall Survival in Phase III Trial

January 31, 2014

Xeloda-Eloxatin Study Updated; Phase III Trial Interim Analysis

December 27, 2002

Amgen Says It Can Demonstrate Safety of Existing Hg Target.

March 16, 2007

NCCN Updates Treatment Guidelines To Include CEF For Early Breast Cancer.

January 26, 2001

Regulatory Agencies: FDA Regulation Of Tobacco Signed by President Clinton

September 6, 1996